Author: admin

  • Uranus Leaks More Heat Than We Thought

    Uranus Leaks More Heat Than We Thought

    When Voyager 2 flew past Uranus in 1986, the spacecraft detected a surprisingly low level of internal heat from the planet. Since then, scientists believed Uranus to be the odd one out in our solar system’s family of giant planets—the others being Jupiter, Saturn, and Neptune—who all tend to emit more heat than they absorb from sunlight.

    Now, a new study suggests that scientists may have had the wrong idea about Voyager 2’s data: Uranus does have an internal heat source similar to its planetary siblings. For the study, published Monday in Geophysical Research Letters, researchers analyzed decades of archival data available on the ice giant, finding that Uranus emits 12.5% more internal heat than it absorbs from the Sun. 

    That’s still considerably less heat than the other three giant planets, which emit more than 100% of the solar energy they receive. Nevertheless, the study demonstrates that Uranus doesn’t stray too far from scientists’ general understanding of how giant planets form and evolve. 

    To reach this conclusion, the researchers analyzed data on Uranus’s global energy balance across one full orbit of the Sun, which takes 84 years. The team took this observational data and combined it with computational models, finding big seasonal swings driven by the planet’s wild changes in sunlight exposure. The new findings are consistent with an earlier paper about Uranus’s energy balance, published in Monthly Notices of the Royal Astronomical Society in May.

    That said, neither study offers a clear answer as to why Uranus’s internal heat is much lower than the other gas and ice giants. Uranus may have had a “different interior structure or evolutionary history compared to the other giant planets,” the researchers noted in a statement. The study also found that Uranus’s energy levels change according to its 20-year-long seasons. These fluctuations, along with the planet’s heat budget, “provide observational constraints that can be used to develop theories of planetary formation for giant planets,” the study states. 

    Thus, the paper both answers and raises questions about Uranus, which the researchers cite as a good reason for future NASA missions to investigate the icy planet further. 

    “By uncovering how Uranus stores and loses heat, we gain valuable insights into the fundamental processes that shape planetary atmospheres, weather systems, and climate systems,” said Liming Li, study co-author and physicist at the University of Houston, in the release. “These findings help broaden our perspective on Earth’s atmospheric system and the challenges of climate change.”

    Continue Reading

  • Xbox tests letting you stream your own games on PC

    Xbox tests letting you stream your own games on PC

    Xbox is bringing its “stream your own game” feature to PC. On Tuesday, the company announced that Xbox Insiders with a Game Pass Ultimate subscription can try streaming the Xbox games they own, including some that are available on console only, directly from the Xbox PC app.

    Bringing the feature to PC is especially helpful, as it will help users conserve storage when playing games with massive file sizes like Call of Duty: Black Ops 6, which requires 128GB of free SSD space. Xbox currently lets users stream more than 250 games from their libraries, in addition to the ones they get through Game Pass. The company says it plans on adding more console-only games and Play Anywhere titles to its list in the future.

    Continue Reading

  • TMP-SMX in pregnancy linked to higher risk of infant birth defects

    TMP-SMX in pregnancy linked to higher risk of infant birth defects

    TMP-SMX in pregnancy linked to higher risk of infant birth defects | Image Credit: © Louis-Photo – © Louis-Photo – stock.adobe.com.

    Trimethoprim-sulfamethoxazole (TMP-SMX) exposure increases malformation risks among infants vs β-lactam antibiotic exposure, according to a recent study published in JAMA Network Open.1

    Urinary tract infections (UTIs) present in pregnant patients more often than any other infection, increasing the risk of adverse perinatal outcomes such as low birth weight, preterm birth, pyelonephritis, and maternal sepsis.2 Therefore, antibiotic treatments such as TMP-SMX are often used in the first trimester of pregnancy, despite concerns about associated malformations.1

    “Evidence regarding antibiotic safety in pregnancy is needed to guide clinical practice,” wrote investigators. “We evaluated whether nitrofurantoin, TMP-SMX, or fluoroquinolones were associated with congenital malformations (any and by organ system) compared with other antibiotics commonly used to treat UTIs.”

    Comparing antibiotic safety during pregnancy

    Study participants included pregnant patients provided antibiotic therapy to manage UTI during the first trimester. Infants of these individuals were also included in the analysis.

    Additional eligibility criteria included prescription drug coverage from 3 months before the last menstrual period to 1 month after pregnancy, first-trimester outpatient dispensing of an antibiotic against UTIs, and a UTI indication within 7 days of the index indication. Patients with more than 1 UTI-related antibiotic in the first trimester, a supply of index prescription lasting over 14 days, or infection-related hospitalization were excluded.

    Oral antibiotic dispensings were identified from outpatient pharmacy claims. These included nitrofurantoin, TMP-SMX, fluoroquinolones, and β-lactams, with β-lactams used as a reference group.

    Congenital malformations were reported as the primary outcome, identified using validated algorithms assessing inpatient and outpatient diagnosis codes. Codes for the first month were assessed for the birthing person vs up to 365 days after birth for the infant. Covariates included demographics, comorbidities, suspected teratogenic medications, and nonindex antibiotics.

    Antibiotic usage and malformation rates

    There were 71,604 pregnancies included in the final analysis. Of pregnant patients, 59.2% used nitrofurantoin in the first trimester, while 4.9% used TMP-SMX, 5.1% fluoroquinolones, and 30.8% β-lactams. Participants were aged a mean of 30 years, and 98.6% had a single pregnancy. Most patient characteristics were similar across agents.

    Malformations were identified in 1518 infants, 729 of whom had cardiac malformations. Overall, an unadjusted absolute risk for any malformation of 19.8 per 1000 infants was reported for β-lactams, vs 21.2 per 1000 for nitrofurantoin, 23.5 per 1000 for fluoroquinolones, and 26.9 per 1000 for TMP-SMX.

    Similar patterns were found for cardiac malformations. Overall, the weighted risk ratio (RR) for any malformation among infants exposed to TMP-SMX vs β-lactams was 1.35. One additional malformation was indicated for every 145 pregnancies exposed to TMP-SMX.

    Nitrofurantoin-exposed infants had a similar risk of any malformation compared to β-lactam–exposed infants, with a weighted RR of 1.12. For fluoroquinolone-exposed infants, the weighted RR was 1.18.

    Organ-specific risks and notable findings

    TMP-SMX–exposed pregnancies had an RR of 1.45 for cardiac malformation compared to β-lactam–exposed pregnancies, indicating a similar risk. However, orofacial and respiratory malformations had increased risks on a relative scale, with an RR of 2.89.

    When restricting analyses to specific malformation groups, increased risks of severe cardiac malformations, other cardiac malformations, and cleft lip and cleft palate were reported in infants exposed to TMP-SMX during pregnancy vs β-lactam. However, these risks were only observed on a relative scale and not an absolute scale.

    These results indicated that the use of first-trimester TMP-SMX to treat UTIs increases the risk of any malformation, severe cardiac malformation, other cardiac malformation, and cleft lip and palate in infants vs β-lactam. However, the data indicated no increased risk for nitrofurantoin.

    “Our results support the current ACOG recommendation for caution in using TMP-SMX during the first trimester but do not support current recommendations to limit nitrofurantoin use,” wrote investigators.

    References

    1. Osmundson SS, Nickel KB, Shortreed SM, et al. First-trimester antibiotic use for urinary tract infection and risk of congenital malformations. JAMA Netw Open. 2025;8(7):e2519544. doi:10.1001/jamanetworkopen.2025.19544
    2. Kazemier BM, Koningstein FN, Schneeberger C, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial.Lancet Infect Dis. 2015;15(11):1324-1333. doi:10.1016/S1473-3099(15)00070-5

    Continue Reading

  • Neurons use built-in ‘backup batteries’ that fuel the brain under stress

    Neurons use built-in ‘backup batteries’ that fuel the brain under stress

     

    Co-author Daniel Colón-Ramos, the Dorys McConnell Duberg Professor of Neuroscience and Cell Biology at YSM, said the study supports the notion of glycogen as an “energy capacitor” in neurons. 

    “Just like in muscles, this reserve can buffer rapid shifts in energy demand,” Colón-Ramos said. “That flexibility might be crucial for how the brain maintains function and responds to stress. This research reshapes our understanding of brain energy metabolism and opens new avenues for exploring how to protect and support neuronal function in disease.”

    Other authors, all from Yale, include Sarah Emerson, a postdoctoral researcher in neuroscience; Ian J. Gonzalez, a graduate student in cell biology; Anjali A. Vishwanath and Anastasia Tsives, post-doctoral researchers in neuroscience; and Richard Goodman, a research scientist in neuroscience.

    Continue Reading

  • First Person: How many more children must die before the world acts? – UN News

    1. First Person: How many more children must die before the world acts?  UN News
    2. Food shortages in Gaza are pushing children to the brink: UNRWA  Dawn
    3. Gaza is running out of blood  Al Jazeera
    4. Displaced Palestinians wait to receive free food in Gaza City  Xinhua
    5. Humanitarian Situation Update #304 | Gaza Strip  ochaopt.org

    Continue Reading

  • Before iOS 26, Apple Will Release at Least One More iOS 18 Update Soon

    Before iOS 26, Apple Will Release at Least One More iOS 18 Update Soon

    Before Apple releases iOS 26 this fall, the company will likely release iOS 18.6 in the next few weeks. The company released the third public beta of the software on July 15, but it didn’t change much on the iPhones of developers and beta testers. While iOS 26 will bring a major redesign to iPhones, the latest beta is filled with bug and security fixes, so developers and beta testers shouldn’t expect new features.

    The iOS 18.6 public beta 3 download page.

    Apple/Screenshot by CNET

    Since this is a beta, I recommend downloading it on something other than your primary device. Because this isn’t the final version of iOS 18.6, the update might be buggy, and battery life may be affected, so it’s best to keep those troubles off your primary device.

    Note that the beta is not the final version of iOS 18.6, so more features could land on your iPhone when it is released. Apple will likely release iOS 18.6 to the general public in the next few weeks but an exact release date is unclear. However, iOS 18.6 will likely be the last significant iOS 18 update the company releases before it makes iOS 26 available this fall. 

    Here’s what to expect from iOS 18.6 when it lands on your iPhone.

    This beta is all about security patches and squashing bugs

    If you’re a developer or beta tester, don’t expect much from this beta other than bug and security fixes. After downloading and looking into iOS 18.6 beta 3, I found no new features or noticeable changes. And that’s not surprising considering Apple’s iOS release schedule over the years.

    Apple announced iOS 18 at WWDC 2024 and released iOS 17.6 more than a month later in July. That update was filled with more than 30 important bug fixes and security patches but no new features. Apple recommended that everyone download the update at the time and it was the last major iOS 17 update before the release of iOS 18. 

    Apple did the same thing in July 2023 when it released iOS 16.6. When the tech giant released that update, it was focused on bug fixes and security patches; the next major iOS release was iOS 17.

    Apple is likely shifting gears and focusing more on iOS 26. In fact, the company has already released three developer betas of that iOS software in preparation for its fall release. 

    There will likely be more betas before iOS 18.6 is released to the public, so there’s plenty of time for Apple to add features or change others — but I wouldn’t count on new features. Apple has not announced when it will release iOS 18.6 but because iOS 17.6 and iOS 16.6 were both released in July of 2024 and 2023, respectively, I expect Apple to release iOS 18.6 this month. 

    For more on iOS 18, here’s what you need to know about iOS 18.5 and iOS 18.4, as well as our iOS 18 cheat sheet. You can also check out what you should know about iOS 26.

    Watch this: New Vision Pro and Apple Glasses: Here’s What to Expect Next


    Continue Reading

  • Pokemon Presents Announced for July 2025 With Pikachu Speaker Tease

    Pokemon Presents Announced for July 2025 With Pikachu Speaker Tease

    It’s that time again, trainers: Grab your Pokedex and get ready to catch some new pocket monsters, because we’re about to hear everything on the latest developments in the world of Pokemon.

    The Pokemon Presents July 2025 stream is the first one since Pokemon Day in February. That stream ended up being pretty massive, featuring game announcements and content updates that we heard whispers about from GameFreak’s infamous 2024 data breach.

    While we don’t know what to expect this time around, it’s safe to assume that we’ll hear about the next mainline games, mobile titles, live service updates and more.

    Here’s how you can watch the upcoming Pokemon Direct — and what you can expect to see once you tune into the stream.

    pokemon-presents-promo-hed.png

    We’ve seen an official trailer for Pokemon Legends: Z-A, but the upcoming Pokemon Presents stream could divulge more information about the game.

    Nintendo/Screenshot by CNET

    How to watch July 2025’s Pokemon Presents stream

    The upcoming Pokemon Presents stream will take place on Tuesday, July 22 at 9 a.m. ET. The stream will go live on the official Pokemon YouTube channel. Not sure when July’s Pokemon Presents will go live for you? Here’s when the event starts in your time zone:

    • ET: July 22 at 9 a.m.
    • CT: July 22 at 8 a.m.
    • MT: July 22 at 7 a.m.
    • PT: July 22 at 6 a.m.

    We don’t know exactly how long the event will run, but previous Pokemon Presents streams have ranged from 10 to 20 minutes long, depending on how many announcements are prepared for the stream.

    pokemon-go-anniversary-art

    Pokemon Go just celebrated its ninth anniversary — we can expect to hear more about this mobile game (among others) during the upcoming Pokemon Direct.

    Nintendo/Screenshot by CNET

    What can you expect from Pokemon Presents July 2025?

    This Pokemon Presents stream is positioned at a strange time — Pokemon Legends: Z-A for the Nintendo Switch 2 has already been announced and we have plenty of info (and gameplay footage) available for that game. We might still get a segment that expands on new gameplay mechanics or Pokemon that players will be able to find in this version of the Kalos region, especially Mega forms we haven’t yet seen.

    The official Pokemon Company Japan X account teased this Pokemon Direct with a rather foreboding photo of Pikachu standing in front of some DJ equipment, so we might just hear about a Pokemon rhythm game. Between that, New Pokemon Snap and the return of Mystery Dungeon, I’m loving the reintroduction of bizarre offshoot games.

    It’s also possible that generation 10 will be announced during the presentation. There are usually three years between mainline Pokemon titles, and Pokemon Scarlet and Violet released in 2022. Unless GameFreak is looking to polish the next big games with some extra development time, we’re probably due to hear about the next generation of Pokemon games extremely soon.

    Pokemon Day 2025 featured an announcement for Pokemon Champions, a dedicated Pokemon battling game, but we haven’t heard much about the game since. We could very well get an update about that game during this stream, explaining more about how the game will integrate the series’ long list of battle mechanics and giving us a better idea of when we’ll see a full release.

    Otherwise, the backbone of this presentation will very likely be composed of routine updates and new features for Pokemon mobile and live service games. We can expect to hear about new Pokemon coming to Pokemon Cafe Mix, Pokemon Masters Ex and Pokemon Sleep, with the potential for new playable pocket monsters to be revealed for Pokemon Unite.

    With Pokemon Go changing hands from Niantic to Scopely, it’s also possible that the extremely popular AR game will have announcements that shake up core gameplay features for Pokemon trainers worldwide. The recent addition of the Gold Bottle Cap was already a massive change for the status quo.

    I’d be willing to bet that the next Pokemon TCG Pocket set will be revealed during this Pokemon Presents as well. New expansions are usually teased at the end of each month, which lines up with this stream. The last Pokemon Presents included info about a massive set expansion, too, so the precedent is already set for this reveal.

    If you’re excited for non-gaming Pokemon content, there’s also a chance we’ll see some Pokemon Concierge during the Pokemon Presents July stream. The second season for this slice-of-life Pokemon hotel series is set to release on Netflix in September, so we might catch a scene or two teasing the show and get an official release date.


    Continue Reading

  • Vaping better at helping smokers quit, study finds

    Vaping better at helping smokers quit, study finds

    July 14 (UPI) — Vaping might be more effective than traditional nicotine replacement therapies in helping people quit smoking, a new Australian study says.

    Six-month smoking abstinence rates were three times higher among people using flavored nicotine-laced vape devices, compared to those given nicotine gum or lozenges, researchers reported Monday in the Annals of Internal Medicine. Flavored vapes are restricted in the U.S.

    “Vaporized nicotine products were more effective than nicotine replacement therapy for smoking cessation,” wrote the research team led by Ryan Courtney, an associate professor with the National Drug and Alcohol Research Center at the University of New South Wales in Australia.

    For the study, researchers recruited more than 1,000 Australians receiving government assistance and randomly assigned them to vaping or nicotine replacement. All were interested in trying to quit smoking.

    The vape group received an eight-week supply of vape juice in tobacco, menthol or fruit flavors, while the nicotine replacement group chose an eight-week supply of gum or lozenges.

    All participants also received automated text messages for five weeks that provided behavioral support for their quit attempt, researchers said.

    After six months, more than 28% of people in the vape group remained smoke-free, compared with a little under 10% of those in the nicotine gum or lozenge group, the study found.

    “In the current trial among people experiencing social disadvantage, vaporized nicotine products with flavor choice had greater effectiveness compared with nicotine replacement therapy gum or lozenge when provided in combination with minimal text-message behavioral support,” researchers concluded.

    However, researchers noted that further study is needed to make sure that people will remain smoke-free long-term while using a vape device.

    It’s also unknown whether people are swapping one health risk for another, researchers added.

    “Although current evidence suggests switching completely from cigarette smoking to (vaping) reduces health risks, the long-term health effects of vaping are largely unknown and data are emerging that demonstrate vaping can impact cardiovascular health,” researchers wrote.

    The U.S. government has severely limited the number of flavored tobacco products that are legally available. Kid-friendly flavors like fruit, menthol and dessert, are sold illegally and have been fueling an explosion in retail sales of e-cigarettes, ABC News reported.

    More information

    Johns Hopkins has more on vaping.

    Copyright © 2025 HealthDay. All rights reserved.

    Continue Reading

  • Emmy nominations revealed – with Adolescence up for 13 awards | Ents & Arts News

    Emmy nominations revealed – with Adolescence up for 13 awards | Ents & Arts News

    The 2025 Emmy nominations have been revealed – with British crime drama Adolescence up for 13 awards.

    English actor Owen Cooper, 15, has been nominated for outstanding supporting actor in a limited or anthology series for his role as schoolboy murder suspect Jamie Miller in the show, where each episode was filmed as one continuous shot.

    Fellow UK actor Stephen Graham, 51, is up for outstanding lead actor in a limited or anthology series for his part as Jamie’s father Eddie.

    The Netflix show, which is nominated for outstanding limited or anthology series, sparked a national conservation about online safety when it premiered in March.

    Please use Chrome browser for a more accessible video player


    1:30

    From March: Adolescence writer’s warning

    Other British nominees include Sir Gary Oldman for outstanding lead actor in a drama series for his role in thriller Slow Horses.

    The show itself received a nod for outstanding drama series.

    The latest series of dystopian drama Black Mirror, created by British screenwriter Charlie Brooker, was nominated for outstanding limited or anthology series.

    American actress Rashida Jones is in the running for outstanding actress in a limited or anthology series for her role in the show.

    Read more:
    Adolescence writers invited to discuss show’s themes with MPs
    PM backs campaign to show Adolescence in schools
    Severance star speaks to Sky News

    Sir Gary Oldman in a scene from Slow Horses. Pic: AP
    Image:
    Sir Gary Oldman in a scene from Slow Horses. Pic: AP

    Irish actress Sharon Horgan was nominated for outstanding lead actress in a drama series for Bad Sisters, while Irish actor Colin Farrell received a nomination for The Penguin in the outstanding lead actor in a limited or anthology series category.

    Scottish actor Alan Cumming was nominated for outstanding host on a reality or reality competition programme for his presenting work on the US version of The Traitors, which has also been nominated as the best reality competition show.

    The nominations for the 77th Emmy awards were revealed on Tuesday.

    US thriller Severance from Apple TV+ received the most nominations, with 27, including for the top prize of outstanding drama series alongside Andor, The Pitt, The White Lotus and others.

    Adam Scott and Britt Lower in Severance. Pic: AP
    Image:
    Adam Scott and Britt Lower in Severance. Pic: AP

    The Penguin received the second-most nominations with 24 and will compete for outstanding limited or anthology series against Adolescence among others.

    Hollywood satire The Studio received 23 nominations including in the outstanding comedy series category alongside shows such as Hacks, The Bear, Nobody Wants This and Abbott Elementary.

    Follow the World
    Follow the World

    Listen to The World with Richard Engel and Yalda Hakim every Wednesday

    Tap to follow

    Meanwhile, Harrison Ford, 83, earned his first-ever Emmy nomination for playing a grumpy therapist in comedy-drama series Shrinking.

    He is in the outstanding supporting actor in a comedy series category.

    The awards ceremony will be held in September.

    Continue Reading

  • TechnipFMC Awarded Significant iEPCI™ Contract for Equinor’s Heidrun Extension Offshore Norway

    TechnipFMC Awarded Significant iEPCI™ Contract for Equinor’s Heidrun Extension Offshore Norway

    NEWCASTLE & HOUSTON, July 15, 2025 — TechnipFMC (NYSE: FTI) has been awarded a significant(1) integrated Engineering, Procurement, Construction, and Installation (iEPCI™) contract by Equinor for its Heidrun extension project in the Norwegian North Sea.

    The award follows an integrated Front End Engineering and Design (iFEED™) study by TechnipFMC. The project will enhance the current infrastructure and extend the production lifecycle for the Heidrun platform.

    Jonathan Landes, President, Subsea at TechnipFMC commented: “This direct award highlights the mutual benefit of early engagement, which led to an optimized field layout. We are excited to leverage our iEPCI™ integrated execution to upgrade this important asset for Equinor.”

    (1) For TechnipFMC, a “significant” contract is between $75 million and $250 million. This award was included in inbound orders in the second quarter of 2025.

    Important Information for Investors and Securityholders

    Forward-Looking Statement

    This release contains “forward-looking statements” as defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. The words “expect,” “believe,” “estimated,” and other similar expressions are intended to identify forward-looking statements, which are generally not historical in nature. Such forward-looking statements involve significant risks, uncertainties and assumptions that could cause actual results to differ materially from our historical experience and our present expectations or projections. For information regarding known material factors that could cause actual results to differ from projected results, including our assumptions and projections regarding the expected benefits of the awarded contract, please see our risk factors set forth in our filings with the United States Securities and Exchange Commission, which include our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. We undertake no obligation to publicly update or revise any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required by law.

    ###

    About TechnipFMC

    TechnipFMC is a leading technology provider to the traditional and new energy industries, delivering fully integrated projects, products, and services.

    With our proprietary technologies and comprehensive solutions, we are transforming our clients’ project economics, helping them unlock new possibilities to develop energy resources while reducing carbon intensity and supporting their energy transition ambitions.

    Organized in two business segments — Subsea and Surface Technologies — we will continue to advance the industry with our pioneering integrated ecosystems (such as iEPCI™, iFEED™ and iComplete™), technology leadership and digital innovation.

    Each of our approximately 21,000 employees is driven by a commitment to our clients’ success, and a culture of strong execution, purposeful innovation, and challenging industry conventions.

    TechnipFMC uses its website as a channel of distribution of material company information. To learn more about how we are driving change in the industry, go to www.TechnipFMC.com and follow us on X @TechnipFMC. 

    Contacts

    Investor relations
    Matt Seinsheimer
    Senior Vice President, Investor Relations and Corporate Development
    Tel: +1 281 260 3665
    Email: Matt Seinsheimer

    James Davis
    Director, Investor Relations
    Tel: +1 281 260 3665
    Email: James Davis

    Media relations
    David Willis
    Senior Manager, Public Relations
    Tel: +44 7841 492988
    Email: David Willis

    Continue Reading